Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease.
Journal
Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
received:
01
05
2023
accepted:
05
01
2024
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
2
5
2024
Statut:
epublish
Résumé
Racial, ethnic, and socioeconomic disparities exist in the prevalence and natural history of chronic liver disease, access to care, and clinical outcomes. Solutions to improve health equity range widely, from digital health tools to policy changes. The current review outlines the disparities along the chronic liver disease health care continuum from screening and diagnosis to the management of cirrhosis and considerations of pre-liver and post-liver transplantation. Using a health equity research and implementation science framework, we offer pragmatic strategies to address barriers to implementing high-quality equitable care for patients with chronic liver disease.
Identifiants
pubmed: 38696374
doi: 10.1097/HC9.0000000000000413
pii: 02009842-202405010-00013
pii:
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
Références
Asrani SK, Kouznetsova M, Ogola G, Taylor T, Masica A, Pope B, et al. Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004–2013. Gastroenterology. 2018;155:719–729.e4.
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: Observational study. BMJ (Online). 2018;362:k2817.
WHO. Global health estimates 2015: Deaths by cause, age, sex, by country and by region, 2000–2015. Global Health Estimates Technical Paper. 2017 doi:10.1016/j.mpmed.2016.06.006
Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2018 annual data report: Liver. Am J Transplant. 2020;20(s1):193–299.
Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology. 2023;77:1382–1403.
Kardashian A, Wilder J, Terrault NA, Price JC. Addressing social determinants of liver disease during the COVID-19 pandemic and beyond: A call to action. Hepatology. 2021;73:811–820.
Nephew LD, Serper M. Racial, gender, and socioeconomic disparities in liver transplantation. Liver Transpl. 2021;27:900–912.
Deutsch-Link S, Bittermann T, Nephew L, Ross-Driscoll K, Weinberg EM, Weinrieb RM, et al. Racial and ethnic disparities in psychosocial evaluation and liver transplant waitlisting. Am J Transplant. 2023;23:776–785.
Northwestern Medicine. African American Transplant Access Program. Accessed March 23, 2023. https://www.nm.org/conditions-and-care-areas/organ-transplantation/african-american-transplant-access-program.
Yoon YH, Chen CM. Surveillance Report #111: Liver cirrhosis mortality in the United States: National, state, and regional trends 2000–2015. U.S Department Of Health and Human Services; Public Health Service; National Institutes of Health; 2014.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–333.
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA—J Am Med Assoc. 2018;320:1899.
Velasco-Mondragon E, Jimenez A, Palladino-Davis AG, Davis D, Escamilla-Cejudo JA. Hispanic health in the USA: A scoping review of the literature. Public Health Rev. 2016;37:31.
Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:198–210.e2.
Cooksey Stowers K, Jiang Q, Atoloye A, Lucan S, Gans K. Racial differences in perceived food swamp and food desert exposure and disparities in self-reported dietary habits. Int J Environ Res Public Health. 2020;17:7143.
Morrill KE, Crocker RM, Hingle MD, Thomson CA, Garcia DO. Awareness, knowledge, and misperceptions related to nonalcoholic fatty liver disease in a community sample of Mexican-origin women: A mixed methods study. Front Public Health. 2021;9:626428.
Davyduke T, Tandon P, Al‐Karaghouli M, Abraldes JG, Ma MM. Impact of implementing a “FIB-4 First” strategy on a pathway for patients with NAFLD referred from primary care. Hepatol Commun. 2019;3:1322–1333.
Chalmers J, Wilkes E, Harris R, Kent L, Kinra S, Aithal G, et al. Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community. Frontline Gastroenterol. 2020;11:86–92.
Shaheen AA, Riazi K, Medellin A, Bhayana D, Kaplan GG, Jiang J, et al. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: A cross-sectional study. CMAJ Open. 2020;8:E370–E376.
Ouzan D, Mosnier A, Penaranda G, Daviaud I, Joly H, Muntlak M, et al. Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease. Eur J Gastroenterol Hepatol. 2021;33:e986–e991.
Harman DJ, Ryder SD, James MW, Jelpke M, Ottey DS, Wilkes EA, et al. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: A cross-sectional diagnostic study utilising transient elastography. BMJ Open. 2015;5:e007516.
Harris R, Card TR, Delahooke T, Aithal GP, Guha IN. Obesity is the most common risk factor for chronic liver disease: Results from a risk stratification pathway using transient elastography. Am J Gastroenterol. 2019;114:1744–1752.
Ginès P, Castera L, Lammert F, Graupera I, Serra‐Burriel M, Allen AM, et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022;75:219–228.
van Dijk AM, Vali Y, Mak AL, Galenkamp H, Nieuwdorp M, van den Born BJ, et al. Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS study. Hepatol Commun. 2022;7:e2109.
Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: Meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216.
Ancker JS, Edwards A, Nosal S, Hauser D, Mauer E, Kaushal R. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak. 2017;17:36.
Spann A, Bishop KM, Weitkamp AO, Stenner SP, Nelson SD, Izzy M. Clinical decision support automates care gap detection among primary care patients with nonalcoholic fatty liver disease. Hepatol Commun. 2023;7:e0035–e0035.
Fox RK, Chu JN, Goldman ML, Islam KB, Brandman D. Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients. Hepatol Commun. 2023;7:e0024.
Haroon S, Wooldridge D, Hoogewerf J, Nirantharakumar K, Williams J, Martino L, et al. Information standards for recording alcohol use in electronic health records: Findings from a national consultation. BMC Med Inform Decis Mak. 2018;18:1–11.
Wang ECH, Wright A. Characterizing outpatient problem list completeness and duplications in the electronic health record. J Am Med Inform Assoc. 2020;27:1190–1197.
Getzen E, Ungar L, Mowery D, Jiang X, Long Q. Mining for equitable health: Assessing the impact of missing data in electronic health records. J Biomed Inform. 2023;139:104269.
Alexander M, Loomis AK, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16:130.
Van Vleck TT, Chan L, Coca SG, Craven CK, Do R, Ellis SB, et al. Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression. Int J Med Inform. 2019;129:334–341.
Campbell CA, Hahn RA, Elder R, Brewer R, Chattopadhyay S, Fielding J, et al. The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. Am J Prev Med. 2009;37:556–569.
Rammohan V, Hahn RA, Elder R, Brewer R, Fielding J, Naimi TS, et al. Effects of dram shop liability and enhanced overservice law enforcement initiatives on excessive alcohol consumption and related harms: Two community guide systematic reviews. Am J Prev Med. 2011;41:334–343.
Hahn RA, Kuzara JL, Elder R, Brewer R, Chattopadhyay S, Fielding J, et al. Effectiveness of policies restricting hours of alcohol sales in preventing excessive alcohol consumption and related harms. Am J Prev Med. 2010;39:590–604.
Middleton JC, Hahn RA, Kuzara JL, Elder R, Brewer R, Chattopadhyay S, et al. Effectiveness of policies maintaining or restricting days of alcohol sales on excessive alcohol consumption and related harms. Am J Prev Med. 2010;39:575–589.
Tansil KA, Esser MB, Sandhu P, Reynolds JA, Elder RW, Williamson RS, et al. Alcohol electronic screening and brief intervention: A community guide systematic review. Am J Prev Med. 2016;51:801–811.
Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, et al. Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: A modelling study. Lancet. 2014;383:1655–1664.
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320:1163–1171.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force Recommendation Statement. JAMA—J Am Med Assoc. 2021;326:736.
Anderson LM, Quinn TA, Glanz K, Ramirez G, Kahwati LC, Johnson DB, et al. The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity. A Systematic Review. Am J Prev Med. 2009;37:340–357.
The Community Guide. Obesity: Tech-based coaching/counseling reduce weight. Accessed March 20, 2023. https://www.thecommunityguide.org/findings/obesity-technology-supported-multicomponent-coaching-or-counseling-interventions-reduce.html
The Community Guide. Diabetes prevention: Community health workers. Accessed March 23, 2023. https://www.thecommunityguide.org/findings/diabetes-prevention-interventions-engaging-community-health-workers.html
Alcalá HE, Chen J, Langellier BA, Roby DH, Ortega AN. Impact of the Affordable Care Act on health care access and utilization among latinos. J Am Board Fam Med. 2017;30:52–62.
Martinez-Donate AP, Dsouza N, Cuellar S, Connor G, Zumaeta-Castillo C, Lazo-Elizondo M, et al. Provider perceptions of availability, accessibility, and adequacy of health and behavioral services for Latino immigrants in Philadelphia: a qualitative study. BMC Public Health. 2022;22:1645.
Price JC, Kanner R, Valadao E, Laguardia YS, Duarte M, Terrault NA. Mobile HCV screening in an at-risk urban population identifies significant fibrosis. Top Antivir Med. 2020;28(1 PG-205):abstract.
Westwood G, Meredith P, Atkins S, Greengross P, Schmidt PE, Aspinall RJ. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease. J Hepatol. 2017;67:559–567.
Said A, Gagovic V, Malecki K, Givens ML, Nieto FJ. Primary care practitioners survey of non-alcoholic fatty liver disease. Ann Hepatol. 2013;12:758–765.
Barber T, Toon L, Tandon P, Green LA. Eliciting and understanding primary care and specialist mental models of cirrhosis care: A cognitive task analysis study. Can J Gastroenterol Hepatol. 2021;2021:1–9.
Zhou K, Terrault NA. Gaps in viral hepatitis awareness in the United States in a population-based study. Clin Gastroenterol Hepatol. 2020;18:188–195.e4.
Kasting ML, Giuliano AR, Reich RR, Roetzheim RG, Nelson DR, Shenkman E, et al. Hepatitis C virus screening trends: Serial cross-sectional analysis of the national health interview survey population, 2013–2015. Cancer Epidemiol Biomark Prev. 2018;27:503–513.
Ford MM, Desai PS, Maduro G, Laraque F. Neighborhood inequalities in hepatitis C mortality: Spatial and temporal patterns and associated factors. J Urban Health. 2017;94:746–755.
Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and hepatitis C care continuum in an underserved birth cohort. J Gen Intern Med. 2019;34:2005–2013.
Kim HS, Rotundo L, Yang JD, Kim D, Kothari N, Feurdean M, et al. Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States. J Viral Hepat. 2017;24:1052–1066.
Hyun S, Ko O, Kim S, Ventura WR. Sociocultural barriers to hepatitis B health literacy in an immigrant population: A focus group study in Korean Americans. BMC Public Health. 2021;21:404.
Gonzalez R, Park A, Yakovchenko V, Rogal S, Chartier M, Morgan TR, et al. HCV elimination in the US Department of Veterans Affairs. Clin Liver Dis (Hoboken). 2021;18:1–6.
Frieden TR. A framework for public health action: The health impact pyramid. Am J Public Health. 2010;100:590–595.
Borrell LN, Joseph SP. Health disparities: The role of preventive medicine in closing the gap. Prev Med (Baltim). 2012;55:569–570.
Su GL, Glass L, Tapper EB, Van T, Waljee AK, Sales AE. Virtual consultations through the Veterans Administration SCAN-ECHO Project improves survival for veterans with liver disease. Hepatology. 2018;68:2317–2324.
Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and testing for hepatitis B virus infection: CDC Recommendations—United States, 2023. MMWR Recommend Rep. 2023;72:1–25.
Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4:e559–e567.
Vinikoor MJ, Sinkala E, Kanunga A, Muchimba M, Zanolini A, Saag M, et al. Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia. PLoS One. 2020;15:e0227041.
Sharma S, Carballo M, Feld JJ, Janssen HLA. Immigration and viral hepatitis. J Hepatol. 2015;63:515–522.
Wu Z, Penning MJ, Schimmele CM. Immigrant status and unmet health care needs. Can J Public Health. 2005;96:369–373.
Ahmed S, Shommu NS, Rumana N, Barron GRS, Wicklum S, Turin TC. Barriers to access of primary healthcare by immigrant populations in Canada: A literature review. J Immigr Minor Health. 2016;18:1522–1540.
Dunn JR, Dyck I. Social determinants of health in Canada’s immigrant population: Results from the National Population Health Survey. Soc Sci Med. 2000;51:1573–1593.
Harris R, Harman DJ, Card TR, Aithal GP, Guha IN. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: A systematic review. Lancet Gastroenterol Hepatol. 2017;2:288–297.
Tang E, Torres S, Liu B, Baden R, Bhuket T, Wong RJ. High prevalence of cirrhosis at initial presentation among safety-net adults with chronic hepatitis B virus infection. J Clin Exp Hepatol. 2018;8:235–240.
Asrani SK, Hall L, Hagan M, Sharma S, Yeramaneni S, Trotter J, et al. Trends in chronic liver disease-related hospitalizations: A population-based study. Am J Gastroenterol. 2019;114:98–106.
Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open. 2020;3:e201997.
Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–252.
Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753–759.
Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, et al. How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257–264.
Singal AK, Kuo YF, Arab JP, Bataller R. Racial and health disparities among cirrhosis-related hospitalizations in the USA. J Clin Transl Hepatol. 2022;10:398–404.
Spiewak T, Taefi A, Patel S, Li CS, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol. 2020;20:245.
Brahmania M, Wiskar K, Walley KR, Celi LA, Rush B. Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis. J Gastroenterol Hepatol (Australia). 2021;36:1088–1094.
Wong RJ, Hirode G. The effect of hospital safety-net burden and patient ethnicity on in-hospital mortality among hospitalized patients with cirrhosis. J Clin Gastroenterol. 2021;55:624–630.
Brahmania M, Alotaibi A, Mooney O, Rush B. Treatment in disproportionately minority hospitals is associated with an increased mortality in end-stage liver disease. Eur J Gastroenterol Hepatol. 2021;33:1408–1413.
Bhala N, Cézard G, Ward HJT, Bansal N, Bhopal R. Ethnic variations in liver- and alcohol-related disease hospitalisations and mortality: The Scottish health and ethnicity linkage study. Alcohol Alcohol. 2016;51:593–601.
Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, et al. Development of quality measures in cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2019;69:1787–1797.
Tapper EB, Hao S, Lin M, Mafi JN, McCurdy H, Parikh ND, et al. The quality and outcomes of care provided to patients with cirrhosis by advanced practice providers. Hepatology. 2020;71:225–234.
Bajaj JS, Choudhury AK, Xie Q, Kamath PS, Topazian M, Hayes PC, et al. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: A prospective cohort study for the CLEARED Consortium. Lancet Gastroenterol Hepatol. 2023;8:611–622.
World Hepatitis Day. World Hepatitis Day. Accessed December 1, 2023. https://www.worldhepatitisday.org/
AASLD. International Liver Associations call for official endorsement of World Liver Day. Accessed December 1, 2023. https://www.aasld.org/news/international-liver-associations-call-official-endorsement-world-liver-day
Serper M, Parikh ND, Thiele G, Ovchinsky N, Mehta S, Kuo A, et al. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022;76:251–274.
Tapper EB, Kanwal F, Asrani SK, Ho C, Ovchinsky N, Poterucha J, et al. Patient-reported outcomes in cirrhosis: A scoping review of the literature. Hepatology. 2018;67:2375–2383.
Valery PC, Bernardes CM, Mckillen B, Amarasena S, Stuart KA, Hartel G, et al. The patient’s perspective in cirrhosis: Unmet supportive care needs differ by disease severity, etiology, and age. Hepatol Commun. 2021;5:891–905.
Danos D, Leonardi C, Gilliland A, Shankar S, Srivastava RK, Simonsen N, et al. Increased risk of hepatocellular carcinoma associated with neighborhood concentrated disadvantage. Front Oncol. 2018;8(SEP):375.
Ladhani S, Ohri A, Wong RJ. Disparities in hepatocellular carcinoma surveillance: Dissecting the roles of patient, provider, and health system factors. J Clin Gastroenterol. 2020;54:218–226.
Rich NE, Hester C, Odewole M, Murphy CC, Parikh ND, Marrero JA, et al. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2019;17:551–559.e1.
Wong RJ, Ahmed A. Understanding gaps in the hepatocellular carcinoma cascade of care: Opportunities to improve hepatocellular carcinoma outcomes. J Clin Gastroenterol. 2020;54:850–856.
Goldberg DS, Valderrama A, Kamalakar R, Sansgiry SS, Babajanyan S, Lewis JD. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B. J Viral Hepat. 2015;22:727–736.
Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78:1922–1965.
Wagle NS, Park S, Washburn D, Ohsfeldt RL, Rich NE, Singal AG, et al. Racial, ethnic, and socioeconomic disparities in curative treatment receipt and survival in hepatocellular carcinoma. Hepatol Commun. 2022;6:1186–1197.
Rogal SS, Yakovchenko V, Gonzalez R, Park A, Beste LA, Rozenberg-Ben-Dror K, et al. The hepatic innovation team collaborative: A successful population-based approach to hepatocellular carcinoma surveillance. Cancers (Basel). 2021;13:2251.
Hui S, Sane N, Wang A, Wan L, Bell S, Le S, et al. Hepatocellular carcinoma surveillance in the telehealth era: A single-centre review. J Telemed Telecare. 2023:1357633X2311660. doi:10.1177/1357633X231166032
doi: 10.1177/1357633X231166032
Yakovchenko V, Morgan TR, Miech EJ, Neely B, Lamorte C, Gibson S, et al. Core implementation strategies for improving cirrhosis care in the Veterans Health Administration. Hepatology. 2022;76:404–417.
The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023. Hepatology. 2023;78(S1):S1–S2154. doi:10.1097/HEP.0000000000000580
doi: 10.1097/HEP.0000000000000580
Kansagara D, Papak J, Pasha AS, O’Neil M, Freeman M, Relevo R, et al. Screening for hepatocellular carcinoma in chronic liver disease: A systematic review. Ann Intern Med. 2014;161:261–269.
Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update. Hepatol Int. 2017;11:317–370.
Narasimman M, Hernaez R, Cerda V, Lee M, Yekkaluri S, Khan A, et al. Financial burden of hepatocellular carcinoma screening in patients with cirrhosis. Clin Gastroenterol Hepatol. 2024;22:760–767.e1.
Parikh ND, Tayob N, Al-Jarrah T, Kramer J, Melcher J, Smith D, et al. Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort. JAMA Netw Open. 2022;5:e2223504–e2223504.
Martin P, Dimartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144–1165.
Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, et al. Factors associated with liver transplant referral among patients with cirrhosis at multiple safety-net hospitals. JAMA Netw Open. 2023;6:e2317549.
Warren C, Carpenter AM, Neal D, Andreoni K, Sarosi G, Zarrinpar A. Racial disparity in liver transplantation listing. J Am Coll Surg. 2021;232:526–534.
Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl. 2010;16:1033–1040.
Rosenblatt R, Wahid N, Halazun KJ, Kaplan A, Jesudian A, Lucero C, et al. Black patients have unequal access to listing for liver transplantation in the United States. Hepatology. 2021;74:1523–1532.
Mohamed KA, Ghabril M, Desai A, Orman E, Patidar KR, Holden J, et al. Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation. Liver Transpl. 2022;28:1441–1453.
Nephew LD, Knapp SM, Mohamed KA, Ghabril M, Orman E, Patidar KR, et al. Trends in racial and ethnic disparities in the receipt of lifesaving procedures for hospitalized patients with decompensated cirrhosis in the US, 2009-2018. JAMA Netw Open. 2023;6:e2324539–e2324539.
Kemmer N. Ethnic disparities in liver transplantation. Gastroenterol Hepatol (NY). 2011;7:302–307.
Laster M, Shen JI, Norris KC. Kidney disease among African Americans: A population perspective. Am J Kidney Dis. 2018;72:S3–S7.
Dave S, Dodge JL, Terrault NA, Sarkar M. Racial and ethnic differences in graft loss among female liver transplant recipients. Transplant Proc. 2018;50:1413–1423.
Alvarado M, Schaubel DE, Reddy KR, Bittermann T. Black race is associated with higher rates of early-onset end-stage renal disease and increased mortality following liver transplantation. Liver Transpl. 2021;27:1154–1164.
Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: A cohort study. Lancet. 2002;359:287–293.
Lee BP, Dodge JL, Terrault NA. Changes and mediators of survival disparity among Black liver transplant recipients in the United States. Am J Transplant. 2021;21:3883–3893.
Health Policy Institute|Georgetown University. Cultural competence in health care: Is it important for people with chronic conditions? Accessed December 1, 2023. https://hpi.georgetown.edu/cultural/
Gordon EJ, Reddy E, Gil S, Feinglass J, Rodde J, Abecassis MM, et al. Culturally competent transplant program improves Hispanics’ knowledge and attitudes about live kidney donation and transplant. Prog Transplant. 2014;24:56–68.
Goldberg DS, Levine M, Karp S, Gilroy R, Abt PL. Share 35 changes center level liver acceptance practices. Liver Transpl. 2017;23:604–613.
Huml AM, Sedor JR, Poggio E, Patzer RE, Schold JD. An opt-out model for kidney transplant referral: The time has come. Am J Transplant. 2021;21:32–36.
Patzer RE, Amaral S, Wasse H, Volkova N, Kleinbaum D, McClellan WM. Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol. 2009;20:1333–1340.
Hall YN. Understanding racial differences in deceased-donor kidney transplantation: Geography, poverty, language, and health insurance coverage. Dial Transplant. 2011;40:401–406.
Patzer RE, Perryman JP, Schrager JD, Pastan S, Amaral S, Gazmararian JA, et al. The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant. 2012;12:358–368.
Ku E, Lee BK, McCulloch CE, Roll GR, Grimes B, Adey D, et al. Racial and ethnic disparities in kidney transplant access within a theoretical context of medical eligibility. Transplantation. 2020;104:1437–1444.
Ethics—General considerations in assessment for transplant candidacy—OPTN. Accessed March 23, 2023. https://optn.transplant.hrsa.gov/professionals/by-topic/ethical-considerations/general-considerations-in-assessment-for-transplant-candidacy/
Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology. 2012;143:1261–1265.
Neuberger J, Callaghan C. Organ utilization—the next hurdle in transplantation. Transplant Int. 2020;33:1597–1609.
Glinka J, Sachar Y, Tang E, Brahmania M, Hwang J, Waugh E, et al. Liver transplantation with donation after medical assistance in dying: Case series and systematic review of the literature. Liver Transpl. 2023;29:618–625.
Ceresa CDL, Nasralla D, Pollok JM, Friend PJ. Machine perfusion of the liver: Applications in transplantation and beyond. Nat Rev Gastroenterol Hepatol. 2022;19:199–209.
Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76:819–853.
Rush B, Walley KR, Celi LA, Rajoriya N, Brahmania M. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology. 2017;66:1585–1591.
Patel AA, Walling AM, Ricks-Oddie J, May FP, Saab S. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.
Hansen L, Chang MF, Hiatt S, Dieckmann NF, Lyons KS, Lee CS. Symptom frequency and distress underestimated in decompensated cirrhosis. Dig Dis Sci. 2022;67:4234–4242.
Kaplan A, Fortune B, Ufere N, Brown RS, Rosenblatt R. National trends in location of death in patients with end-stage liver disease. Liver Transpl. 2021;27:165–176.
McMahan RD, Tellez I, Sudore RL. Deconstructing the complexities of advance care planning outcomes: What do we know and where do we go? A scoping review. J Am Geriatr Soc. 2021;69:234–244.
Ufere NN, Brahmania M, Sey M, Teriaky A, El‐Jawahri A, Walley KR, et al. Outcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease. Liver Int. 2019;39:1256–1262.
Rush B, Fruhstofer C, Walley KR, Celi LA, Brahmania M. Palliative medicine and hospital readmissions in end-stage liver disease. BMJ Support Palliat Care. 2019. doi:10.1136/BMJSPCARE-2018-001635
doi: 10.1136/BMJSPCARE-2018-001635
Clark MA, Person SD, Gosline A, Gawande AA, Block SD. Racial and ethnic differences in advance care planning: Results of a statewide population-based survey. J Palliat Med. 2018;21:1078–1085.
Antoniu S, Mihaltan F. Outcome measures for palliative oxygen therapy: Relevance and practical utility. Expert Rev Pharmacoecon Outcomes Res. 2014;14:417–423.
Alexander GC, Sehgal AR. Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis. 2001;37:321–328.
Axelrod DA, Pomfret EA. Race and sex disparities in liver transplantation progress toward achieving equal access? JAMA. 2008;300:2425.
Bryce CL, Angus DC, Arnold RM, Chang CCH, Farrell MH, Manzarbeitia C, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092–2101.
Gaylin DS, Held PJ, Port FK, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA: J Am Med Assoc. 1993;269:603.